Optimal stroke prevention in the geriatric patient with atrial fibrillation: Position paper of an interdisciplinary expert panel

Drug Research

Volumn 65, Issue 10, 2014, Pages 505-514

  Bahrmann, P ^a   Wehling, M ^b   Ropers, D ^a   Flohr, J ^c   Leischker, A ^d   Rother J ^e  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c General Medicine Practice   (Germany)

^d Krankenhaus Maria Hilf   (Germany)

^e ASKLEPIOS KLINIK ALTONA   (Germany)

Author keywords

adherence; anticoagulation; assessment; atrial fibrillation; geriatrics; interdisciplinary management; novel anticoagulants; older patients; prevention; stroke

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; CLOPIDOGREL; DABIGATRAN; DABIGATRAN ETEXILATE; HEPARIN; RIVAROXABAN; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BARTHEL INDEX; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; COGNITION; DAILY LIFE ACTIVITY; ELECTROCARDIOGRAM; FALLING; GAIT; GENERAL PRACTITIONER; GERIATRIC ASSESSMENT; GERIATRIC DEPRESSION SCALE; GERIATRIC DISORDER; GERIATRIC PATIENT; GERIATRICIAN; GLOMERULUS FILTRATION RATE; HOLTER MONITORING; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; META ANALYSIS (TOPIC); MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; SELF CARE; TIMED TEST OF MONEY COUNTING; TRANSIENT ISCHEMIC ATTACK; AGE; AGED; BLEEDING; CHEMICALLY INDUCED; COMPLICATION; RISK; STROKE; VERY ELDERLY;

ACCIDENTAL FALLS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; HEMORRHAGE; HUMANS; RISK; STROKE;

EID: 84943538008     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0034-1389984     Document Type: Review

References (90)

1. Camm A. J., Kirchhof P., Lip G. Y. et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J: 2010; 31 2369 2429
2. Heeringa J., van der Kuip D. A., Hofman A. et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J: 2006; 27 949 953
3. Rabunal-Rey R., Monte-Secades R., Gomez-Gigirey A. et al. Electrocardiographic abnormalities in centenarians: impact on survival. BMC Geriatr: 2012; 12 15
4. Ohlmeier C., Mikolajczyk R., Haverkamp W. et al. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace: 2013; 15 1436 1444
5. Wann L. S., Curtis A. B., January C. T. et al. ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol: 2011; 57 223 242
6. Camm A., Lip G., Atar D. et al. 2012 Focused Update of the ESC Guidelines on the Management of Atrial Fibrillation. Eur Heart J: 2012; 33 2719 2747
7. Deutsche Gesellschaft für Geriatrie Der geriatrische Patient (Definition). Internet http://www.dggeriatrie.de/ Accessed on 1 June 2014
8. Savelieva I., Bajpai A., Camm A. J. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med: 2007; 39 371 391
9. Goto S., Bhatt D. L., Rother J. et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J: 2008; 156 855 863 63 e2
10. Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke: 1991; 22 983 988
11. Marini C., De Santis F., Sacco S. et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke: 2005; 36 1115 1119
12. Lin H. J., Wolf P. A., Kelly-Hayes M. et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke: 1996; 27 1760 1764
13. Steger C., Pratter A., Martinek-Bregel M. et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J: 2004; 25 1734 1740
14. Singer D. E., Chang Y., Fang M. C. et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med: 2009; 151 297 305
15. Mant J., Hobbs F. D., Fletcher K. et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet: 2007; 370 493 503
16. Haeusler K. G., Konieczny M., Endres M. et al. Impact of anticoagulation before stroke on stroke severity and long-term survival. Int J Stroke: 2012; 7 544 550
17. Connolly S. J., Ezekowitz M. D., Yusuf S. et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med: 2009; 361 1139 1151
18. Patel M. R., Mahaffey K. W., Garg J. et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med: 2011; 365 883 891
19. Ntaios G., Papavasileiou V., Diener H. C. et al. Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials. Stroke: 2012; 43 3298 3304
20. Lopes R. D., Crowley M. J., Shah B. R. et al. Stroke Prevention in Atrial Fibrillation. Agency for Healthcare Research and Quality (US); August 2013. Report No.: 13-EHC113-EF. AHRQ Comparative Effectiveness Reviews. Accessed on 1 June 2014
21. O'Dell K. M., Igawa D., Hsin J. New oral anticoagulants for atrial fibrillation: a review of clinical trials. Clin Ther: 2012; 34 894 901
22. Schneeweiss S., Gagne J. J., Patrick A. R. et al. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes: 2012; 5 480 486
23. Shibazaki K., Kimura K., Aoki J. et al. Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation. J Neurol Sci: 2013; 331 90 93
24. Ten Cate H. New oral anticoagulants: discussion on monitoring and adherence should start now! Thromb J: 2013; 11 8
25. Endres M., Diener H., Röther J. Sekundärprophylaxe des ischämischern Insults. In: Diener H. C. et al. Hrsg Leitlinien für Diagnostik und Therapie in der Neurologie. 5. Auflage Stuttgart Thieme: 2012; 324 347
26. Diener H-C, Eikelboom J., Connolly S. J. et al. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. 101016/S1474-4422(08)70087-5: 2012; 11 225 231
27. Connolly S. J., Eikelboom J., Joyner C. et al. Apixaban in patients with atrial fibrillation. N Engl J Med: 2011; 364 806 817
28. Conroy S. P., Ansari K., Williams M. et al. A controlled evaluation of comprehensive geriatric assessment in the emergency department: the 'Emergency Frailty Unit' Age Ageing: 2013; Epub ahead of print 23 July) 43 109 114
29. Ramjaun A., Nassif M. O., Krotneva S. et al. Improved targeting of cancer care for older patients: A systematic review of the utility of comprehensive geriatric assessment. J Geriatr Oncol: 2013; 4 271 281
30. Grassel E. Use of psychopathometric procedures in diagnosis of dementia exemplified by a comparison between the Mini-Mental State and the MWT/KAI (Multiple-Choice Vocabulary/General Intelligence Test Short-Form) test system. Z Gerontol: 1993; 26 268 274
31. Tombaugh T. N., McIntyre N. J. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc: 1992; 40 922 935
32. Mainlan B. J., Amodeo S., Shulman K. I. Multiple clock drawing scoring systems: simpler is better. Int J Geriatr Psychiatry: 2013
33. Shulman K. I. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry: 2000; 15 548 561
34. Kessler J., Calabrese P., Kalbe E. et al. DemTect. Ein neues Screening-Verfahren zur Unterstützung der Demenzdiagnostik. Psychol Addict Behav: 2000; 6 343 347
35. Nikolaus T., Bach M., Specht-Leible N. et al. The Timed Test of Money Counting: a short physical performance test for manual dexterity and cognitive capacity. Age Ageing: 1995; 24 257 258
36. Podsiadlo D., Richardson S. The timed Up & Go: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc: 1991; 39 142 148
37. Kassenärztliche Bundesvereinigung (KVB) Hausarzt-EBM. Internet http://www.kbv.de/43707.html Accessed on 1 July 2014
38. GeriNet Leipzig e.V Aims and description of the network. Internet http://gerinet-leipzig.de/ Accessed on 15 Nov 2013
39. Kirchhof P., Nabauer M., Gerth A. et al. Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Thromb Haemost: 2011; 105 1010 1023
40. Spyropoulos A. C., Bauersachs R. M., Omran H. et al. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin: 2006; 22 1109 1122
41. Hammerstingl C., Schmitz A., Fimmers R. et al. Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry. Cardiovasc Ther: 2009; 27 230 238
42. Kansal A. R., Zheng Y., Pokora T. et al. Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation. Best Pract Res Clin Haematol: 2013; 26 225 237
43. Coyle D., Coyle K., Cameron C. et al. Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation. Value Health: 2013; 16 498 506
44. Srivastava A., Hudson M., Hamoud I. et al. Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy. Thromb J: 2008; 6 6
45. Wittkowsky A. K., Spinler S. A., Dager W. et al. Dosing guidelines, not protocols, for managing warfarin therapy. Am J Health Syst Pharm: 2010; 67 1554 1556
46. Coresh J., Selvin E., Stevens L. A. et al. Prevalence of chronic kidney disease in the United States. JAMA: 2007; 298 2038 2047
47. Hohnloser S. H., Hijazi Z., Thomas L. et al. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J: 2012; 33 2821 2830
48. st edition Hamilton, Ontario, Canada B.C. Decker: 2006; 130 135
49. Townsend R. R. Stroke in Chronic Kidney Disease: Prevention and Management. Clinical Journal of the American Society of Nephrology: 2008; 3 S11 S16
50. Wehling M. Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs. J Am Med Dir Assoc: 2013; 14 437 442
51. Coca S. G. Acute kidney injury in elderly persons. Am J Kidney Dis: 2010; 56 122 131
52. Chronopoulos A., Rosner M. H., Cruz D. N. et al. Acute kidney injury in elderly intensive care patients: a review. Intensive Care Med: 2010; 36 1454 1464
53. Shireman T. I., Mahnken J. D., Howard P. A. et al. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest: 2006; 130 1390 1396
54. Behr S., Andersohn F., Garbe E. Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf: 2010; 19 722 730
55. Samama C. M. New anticoagulants: pharmacology and clinical studies. Wien Med Wochenschr: 2011; 161 54 57
56. Hart R. G., Pearce L. A., Aguilar M. I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med: 2007; 146 857 867
57. Ogilvie I. M., Newton N., Welner S. A. et al. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med: 2010; 123 638 645
58. Nabauer M., Gerth A., Limbourg T. et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace: 2009; 11 423 434
59. Gladstone D. J., Bui E., Fang J. et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke: 2009; 40 235 240
60. Hylek E. M., D'Antonio J., Evans-Molina C. et al. Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. Stroke: 2006; 37 1075 1080
61. Wallentin L., Yusuf S., Ezekowitz M. D. et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet: 2010; 376 975 983
62. Gallagher A. M., Rietbrock S., Plumb J. et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost: 2008; 6 1500 1506
63. Connolly S. J., Ezekowitz M. D., Yusuf S. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med: 2009; 361 1139 1151
64. Granger C. B., Alexander J. H., McMurray JJ V. et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med: 2011; 365 981 992
65. Torn M., Bollen W. L., van der Meer F. J. et al. Risks of oral anticoagulant therapy with increasing age. Arch Intern Med: 2005; 165 1527 1532
66. Friberg L., Rosenqvist M., Lip G. Y. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation: 2012; 125 2298 2307
67. Barco S., Cheung Y. W., Eikelboom J. W. et al. New oral anticoagulants in elderly patients. Best Pract Res Clin Haematol: 2013; 26 215 224
68. Ruiz-Nodar J. M., Marin F., Hurtado J. A. et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol: 2008; 51 818 825
69. DeEugenio D., Kolman L., DeCaro M. et al. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy: 2007; 27 691 696
70. Hamm C. W., Bassand J. P., Agewall S. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J: 2011; 32 2999 3054
71. Oldgren J., Wallentin L., Alexander J. H. et al. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis. Eur Heart J: 2013; 34 1670 1680
72. Dans A. L., Connolly S. J., Wallentin L. et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation: 2013; 127 634 640
73. Dewilde W. J., Oirbans T., Verheugt F. W. et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet: 2013; 381 1107 1115
74. El-Khoury F., Cassou B., Charles M. A. et al. The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials. BMJ: 2013; 347 f6234
75. Poli D., Antonucci E., Testa S. et al. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation: 2011; 124 824 829
76. Donze J., Clair C., Hug B. et al. Risk of falls and major bleeds in patients on oral anticoagulation therapy. Am J Med: 2012; 125 773 778
77. Gage B. F., Birman-Deych E., Kerzner R. et al. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med: 2005; 118 612 617
78. Man-Son-Hing M., Laupacis A. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded. Arch Intern Med: 2003; 163 1580 1586
79. Man-Son-Hing M., Nichol G., Lau A. et al. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med: 1999; 159 677 685
80. Sellers M. B., Newby L. K. Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J: 2011; 161 241 246
81. Inamasu J., Nakatsukasa M., Miyatake S. et al. Influence of warfarin and low-dose aspirin on the outcomes of geriatric patients with traumatic intracranial hemorrhage resulting from ground-level fall. Geriatr Gerontol Int: 2012; 12 667 672
82. Banerjee A., Lane D. A., Torp-Pedersen C. et al. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost: 2012; 107 584 589
83. Steiner T., Bohm M., Dichgans M. et al. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol: 2013; 102 399 412
84. Diener H. C., Foerch C., Riess H. et al. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment. Lancet Neurol: 2013; 12 677 688
85. Poli D., Antonucci E., Testa S. et al. Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thromb Res: 2013; 131 12 16
86. Bischoff-Ferrari H. A., Dawson-Hughes B., Willett W. C. et al. Effect of Vitamin D on falls: a meta-analysis. JAMA: 2004; 291 1999 2006
87. Souchet E., Lapeyre-Mestre M., Montastruc J. L. Drug related falls: a study in the French Pharmacovigilance database. Pharmacoepidemiol Drug Saf: 2005; 14 11 16
88. Cashin R. P., Yang M. Medications prescribed and occurrence of falls in general medicine inpatients. Can J Hosp Pharm: 2011; 64 321 326
89. Bonnemeier H., Bosch R. F., Kohlhaussen A. et al. For The Move Study G. Presentation of atrial fibrillation and its management by cardiologists in the ambulatory and hospital setting: MOVE cross-sectional study. Curr Med Res Opin: 2011; 27 995 1003
90. Meinertz T., Kirch W., Rosin L. et al. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol: 2011; 100 897 905